These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 25690662)
21. Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease. Inspector M; Aharon-Perez J; Glass-Marmor L; Miller A Eur Neurol; 2005; 53(3):155-7. PubMed ID: 15942243 [No Abstract] [Full Text] [Related]
22. Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease. Smith ER; Nilforooshan R; Weaving G; Tabet N J Alzheimers Dis; 2011; 24(2):327-33. PubMed ID: 21239851 [TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung GY; Sadovnick AD; Feldman H CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624 [TBL] [Abstract][Full Text] [Related]
24. Potential utility of soluble p3-alcadein α plasma levels as a biomarker for sporadic Alzheimer's disease. Kamogawa K; Kohara K; Tabara Y; Takita R; Miki T; Konno T; Hata S; Suzuki T J Alzheimers Dis; 2012; 31(2):421-8. PubMed ID: 22571980 [TBL] [Abstract][Full Text] [Related]
25. The effect of depression on serum VEGF level in Alzheimer's disease. Jung J; Kim S; Yoon K; Moon Y; Roh D; Lee S; Choi K; Jung J; Kim D Dis Markers; 2015; 2015():742612. PubMed ID: 25838619 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670 [TBL] [Abstract][Full Text] [Related]
28. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Fukumoto H; Tennis M; Locascio JJ; Hyman BT; Growdon JH; Irizarry MC Arch Neurol; 2003 Jul; 60(7):958-64. PubMed ID: 12873852 [TBL] [Abstract][Full Text] [Related]
29. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
30. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls. Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805 [TBL] [Abstract][Full Text] [Related]
31. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
32. Plasma leptin levels and free leptin index in women with Alzheimer's disease. Baranowska-Bik A; Bik W; Styczynska M; Chodakowska-Zebrowska M; Barcikowska M; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B Neuropeptides; 2015 Aug; 52():73-8. PubMed ID: 26070219 [TBL] [Abstract][Full Text] [Related]
33. Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease. Xu XY; Deng CQ; Wang J; Deng XJ; Xiao Q; Li Y; He Q; Fan WH; Quan FY; Zhu YP; Cheng P; Chen GJ Int J Neurosci; 2017 May; 127(5):454-458. PubMed ID: 27323891 [TBL] [Abstract][Full Text] [Related]
34. Elevated angiopoietin-1 serum levels in patients with Alzheimer's disease. Schreitmüller B; Leyhe T; Stransky E; Köhler N; Laske C Int J Alzheimers Dis; 2012; 2012():324016. PubMed ID: 23094194 [TBL] [Abstract][Full Text] [Related]
35. Altered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer's Disease. Park JH; Cho SJ; Jo C; Park MH; Han C; Kim EJ; Huh GY; Koh YH J Pers Med; 2022 May; 12(5):. PubMed ID: 35629249 [TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients. Hochstrasser T; Ehrlich D; Marksteiner J; Sperner-Unterweger B; Humpel C Curr Alzheimer Res; 2012 Oct; 9(8):982-9. PubMed ID: 21875409 [TBL] [Abstract][Full Text] [Related]
38. Plasma adiponectin array in women with Alzheimer's disease. Baranowska-Bik A; Kalisz M; Martyńska L; Wolińska-Witort E; Styczyńska M; Chodakowska-Żebrowska M; Barcikowska M; Baranowska B; Bik W Endokrynol Pol; 2018; 69(5):550-559. PubMed ID: 30117532 [TBL] [Abstract][Full Text] [Related]